Cargando…
Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review
Background and Aims: Hypercholesterolemia is a common finding in patients with primary biliary cholangitis (PBC) and is a well-defined risk factor for cardiovascular disease. However, studies have been mixed on whether PBC patients do, in fact, have higher cardiovascular risk. The aim of this study...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018312/ https://www.ncbi.nlm.nih.gov/pubmed/29951355 http://dx.doi.org/10.14218/JCTH.2017.00064 |
_version_ | 1783334930232639488 |
---|---|
author | Suraweera, Duminda Fanous, Christina Jimenez, Melissa Tong, Myron J. Saab, Sammy |
author_facet | Suraweera, Duminda Fanous, Christina Jimenez, Melissa Tong, Myron J. Saab, Sammy |
author_sort | Suraweera, Duminda |
collection | PubMed |
description | Background and Aims: Hypercholesterolemia is a common finding in patients with primary biliary cholangitis (PBC) and is a well-defined risk factor for cardiovascular disease. However, studies have been mixed on whether PBC patients do, in fact, have higher cardiovascular risk. The aim of this study is to review the current literature and provide an evidence-based assessment of cardiovascular risk in PBC patients. Methods: We performed a systematic literature search on PubMed regarding patients with PBC and cardiovascular events from the database inception to July 1, 2017. A total of 33 articles fulfilling our inclusion criteria were found. Results: The majority of the studies evaluated yielded no statistically significant difference in cardiovascular disease in the PBC population compared to the general public. However, some reports found a statistically significantly increase in coronary artery disease. Several studies have looked at the specific lipid profile of patients with PBC with hypocholesteremia. While these lipid abnormalities differ by stage of disease, there is evidence to suggest that the specific lipid profile in PBC may have lower atherogenicity than in patients with hypercholesterolemia without PBC. Studies looking at patients with PBC with other risk factors for cardiovascular disease, such as hypertension and metabolic syndrome, have consistently found a higher risk for cardiovascular disease in these patients. Statin treatment is effective in reducing lipid levels and possibly improving endothelial inflammation in patients with PBC with hypercholesterolemia. Conclusions: There is not enough evidence to suggest an increased risk of cardiovascular disease in patients with PBC with hypercholesterolemia, except for those individuals with concomitant features of metabolic syndrome. In patients with PBC with no additional cardiovascular risk factors, individual risk/benefit discussion on lipid-lowering treatment should be considered. |
format | Online Article Text |
id | pubmed-6018312 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | XIA & HE Publishing Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60183122018-06-27 Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review Suraweera, Duminda Fanous, Christina Jimenez, Melissa Tong, Myron J. Saab, Sammy J Clin Transl Hepatol Original Article Background and Aims: Hypercholesterolemia is a common finding in patients with primary biliary cholangitis (PBC) and is a well-defined risk factor for cardiovascular disease. However, studies have been mixed on whether PBC patients do, in fact, have higher cardiovascular risk. The aim of this study is to review the current literature and provide an evidence-based assessment of cardiovascular risk in PBC patients. Methods: We performed a systematic literature search on PubMed regarding patients with PBC and cardiovascular events from the database inception to July 1, 2017. A total of 33 articles fulfilling our inclusion criteria were found. Results: The majority of the studies evaluated yielded no statistically significant difference in cardiovascular disease in the PBC population compared to the general public. However, some reports found a statistically significantly increase in coronary artery disease. Several studies have looked at the specific lipid profile of patients with PBC with hypocholesteremia. While these lipid abnormalities differ by stage of disease, there is evidence to suggest that the specific lipid profile in PBC may have lower atherogenicity than in patients with hypercholesterolemia without PBC. Studies looking at patients with PBC with other risk factors for cardiovascular disease, such as hypertension and metabolic syndrome, have consistently found a higher risk for cardiovascular disease in these patients. Statin treatment is effective in reducing lipid levels and possibly improving endothelial inflammation in patients with PBC with hypercholesterolemia. Conclusions: There is not enough evidence to suggest an increased risk of cardiovascular disease in patients with PBC with hypercholesterolemia, except for those individuals with concomitant features of metabolic syndrome. In patients with PBC with no additional cardiovascular risk factors, individual risk/benefit discussion on lipid-lowering treatment should be considered. XIA & HE Publishing Inc. 2018-02-14 2018-06-28 /pmc/articles/PMC6018312/ /pubmed/29951355 http://dx.doi.org/10.14218/JCTH.2017.00064 Text en © 2018 Authors. http://creativecommons.org/licenses/by-nc/4.0/ This article has been published under the terms of Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which permits noncommercial unrestricted use, distribution, and reproduction in any medium, provided that the following statement is provided. “This article has been published in Journal of Clinical and Translational Hepatology at DOI: 10.14218/JCTH.2017.00064 and can also be viewed on the Journal’s website at http://www.jcthnet.com”. |
spellingShingle | Original Article Suraweera, Duminda Fanous, Christina Jimenez, Melissa Tong, Myron J. Saab, Sammy Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title_full | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title_fullStr | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title_full_unstemmed | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title_short | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review |
title_sort | risk of cardiovascular events in patients with primary biliary cholangitis - systematic review |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018312/ https://www.ncbi.nlm.nih.gov/pubmed/29951355 http://dx.doi.org/10.14218/JCTH.2017.00064 |
work_keys_str_mv | AT suraweeraduminda riskofcardiovasculareventsinpatientswithprimarybiliarycholangitissystematicreview AT fanouschristina riskofcardiovasculareventsinpatientswithprimarybiliarycholangitissystematicreview AT jimenezmelissa riskofcardiovasculareventsinpatientswithprimarybiliarycholangitissystematicreview AT tongmyronj riskofcardiovasculareventsinpatientswithprimarybiliarycholangitissystematicreview AT saabsammy riskofcardiovasculareventsinpatientswithprimarybiliarycholangitissystematicreview |